Approval · Notice of Compliance 738 · 2003
LUVOX: Notice of Compliance 738
Issued September 4, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 738
- Date
- September 4, 2003
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph: adverse effects following discontinuation of treatment
- Therapeutic class
- Antidepressant, antiobsessional agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUVOX | Not yet assigned | — |
Medicinal ingredients
- FLUVOXAMINE MALEATE 50 MG per TAB
- FLUVOXAMINE MALEATE 100 MG per TAB